TET2 and acute myeloid leukemia: A 65-year-old woman was diagnosed with acute myeloid leukemia (AML-M2a subtype) on July 18, 2023,accompanied by mutations in FMS‐like tyrosine kinase 3 (FLT3)-ITD, NPM1, TET2, EZH2, and other genes.